Welcome to The Budning Eye Institute on-line
At the Budning Eye Institute our goal is to provide you with the highest
quality eye care. Quality care includes a good understanding of your child's eye condition. This web site has been constructed
to help provide you with this information, as well as issues surrounding
As you navigate this web site you will find sections discussing medical
and surgical eye conditions, treatments and answers to common questions.
This site includes our contact information, the best ways to reach
us and how to book your appointment by email.
Please inform us if you are unable to
attend your appointment. Missed appointment charges apply.
Please see Uninsured services for details.
Botulinum Toxin for strabismus
toxin was first used to weaken eye muscles in 1979. Since that time much
research has been done on the safety and applications for this medicine.
It has been found that there are many instances of Squint (Strabismus or
crossed eyes) where application of Botulinum toxin (Botox - Allergan)
can be of great benefit. For more information see the section on
Botulinum toxin under Medical.
Dr. Andrew Budning
Since finishing his fellowship in Pediatric Ophthalmology and Strabismus
in 1992, Dr. Budning has had the opportunity to excel and demonstrate
excellence in this subspecialty, along with maintaining great expertise
in general ophthalmology and Cataract surgery . He has established a
national and international presence in the management of Retinoblastoma,
Coats’ disease and strabismus. In the case of Coats’ disease he has
published one of the largest most complete studies to date, including
the most innovative and effective treatment yet described.
Dr. Budning has demonstrated excellence in teaching at the graduate and
postgraduate levels in all areas of pediatric ophthalmology. He has
provided a great deal of insight thought and perspective in his
lectures; which have formed part of the University or Toronto core
Dr. Budning has played and continues to play an important clinical
teaching and research role in the Department of Ophthalmology at the
Hospital for Sick Children in Toronto. Additionally He has demonstrated
a great deal of expertise and resourcefulness when decisions were
required in the areas of technology, optics, and ophthalmic technology.